Kyle C. Garrison, Author at Studio yria

Angola: cómo transformar renta extractiva en capital humano e infraestructura

26

Jun

Private sector WASH investments addressing rural health deficits in Angola’s remote provinces

Angola’s progress since the conflict has strengthened its macroeconomic outlook, yet rural populations continue to struggle with limited access to safe water and essential preventive health services. Private-sector entities — including oil and gas operators, mining firms, and international companies active in Angola — have launched Corporate Social Responsibility (CSR) initiatives aimed at improving water, sanitation, hygiene (WASH), and preventive healthcare. These efforts often reinforce government and donor programs and can deliver lasting improvements when they are community-driven, technically robust, and aligned with public systems.Context and needDemographics and access gaps: Angola’s population stands in the mid-thirty‑million range, with many residents…

Ghana: mining and agriculture CSR with transparency and sustainable community projects

25

Jun

By Kyle C. Garrison

Social Responsibility

Environmental CSR in Ghana: managing tailings, mercury pollution and ecosystem restoration

Ghana's economy rests on two closely connected pillars: mining and agriculture. Mining, driven by gold, manganese, bauxite, and various industrial minerals, generates substantial export income and government revenues. Agriculture, centered on cocoa, staple crops, and smallholder farming systems, sustains livelihoods for much of the population while feeding into international commodity markets. These sectors both create prosperity and place pressure on ecosystems and local communities. Corporate social responsibility (CSR) and transparency therefore serve not as optional add-ons but as vital mechanisms to reduce environmental risks, safeguard human rights, and secure lasting benefits for surrounding communities.Key CSR challenges in Ghana's mining sectorGhanaian…

Why is AI governance becoming a core requirement for regulated industries?

25

Jun

By Kyle C. Garrison

Science and Technology

AI governance frameworks for credit scoring and risk assessment

Artificial intelligence is swiftly shifting from small-scale trials to essential, high-stakes applications within regulated fields like finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals, and as AI increasingly shapes decisions carrying legal, ethical, and social consequences, oversight has ceased to be optional and is instead evolving into a fundamental obligation driven by regulatory pressure, risk mitigation, and public responsibility.The Growing Influence of AI Across Critical Operational SettingsRegulated industries are increasingly leveraging AI to boost efficiency, enhance precision, and expand operational capacity; for instance, banks rely on credit assessment models, healthcare uses diagnostic algorithms, insurance firms deploy fraud‑detection systems, capital markets employ…

Albania: CSR examples supporting sustainable tourism and cultural heritage protection

16

Jun

By Kyle C. Garrison

Social Responsibility

why CSR is essential for Albania’s cultural heritage and tourism growth

Albania is a nation distinguished by abundant archaeological treasures, varied natural scenery and a swiftly expanding flow of visitors, where sustainable tourism and the safeguarding of cultural heritage remain essential for enduring economic progress, community well-being and the preservation of national identity. When aligned with public policy and supported by civil society, corporate social responsibility can speed up conservation efforts, refine visitor oversight and help ensure tourism-generated gains reach local communities.Why CSR matters for sustainable tourism and heritage protectionResource and capacity gaps: Numerous heritage locations and safeguarded coastal zones often operate with limited public budgets for preservation, visitor facilities, and…

How do companies quantify reputational risk in valuation models?

16

Jun

By Kyle C. Garrison

Investments and Business

Why modern valuation models must include reputational risk

Reputational risk describes the possible decline in a company’s value that arises when stakeholders’ views worsen in response to actual or perceived situations, such as ethical lapses, regulatory violations, faulty products, data protection issues, or environmental damage, and because reputation shapes customer confidence, pricing leverage, talent retention, and the ability to secure capital, it has become a significant element in assessing corporate worth.Contemporary valuation frameworks increasingly seek to measure reputational risk rather than regard it as merely a qualitative issue, and although reputation is intangible, its financial impacts can be detected, assessed, and often prove enduring.Why Reputational Risk Must Be…

What trends are shaping personalized medicine and clinical trial design?

16

Jun

By Kyle C. Garrison

Science and Technology

Transforming clinical trial design through personalized medicine and data science

Personalized medicine seeks to adjust prevention, diagnosis, and treatment to each patient’s distinct biological makeup, environmental context, and lifestyle habits, and over the past decade this vision has steadily shifted into routine practice, influencing how therapies are created and how clinical trials take shape. Progress in genomics, data science, and digital health continues to drive this evolution, while regulatory bodies and healthcare institutions adapt to encourage more precise, individualized, and patient-focused research frameworks.Genomics and Multi-Omics as Cornerstones of ProgressThe dramatic decrease in genome sequencing expenses, combined with the growing adoption of multi-omics techniques, has profoundly reshaped personalized medicine.Genomics: Through whole-genome…

How are AI and protein folding tools accelerating drug discovery?

16

Jun

By Kyle C. Garrison

Science and Technology

the future of drug discovery powered by AI and protein folding

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Essential Importance of Protein Architecture in Contemporary Drug DevelopmentMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent…